Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Assets: 2009-2025

Historic Current Assets for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $2.3 million.

  • China Pharma Holdings' Current Assets fell 37.70% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 37.70%. This contributed to the annual value of $3.3 million for FY2024, which is 45.47% down from last year.
  • Latest data reveals that China Pharma Holdings reported Current Assets of $2.3 million as of Q3 2025, which was down 13.75% from $2.7 million recorded in Q2 2025.
  • China Pharma Holdings' 5-year Current Assets high stood at $9.1 million for Q4 2021, and its period low was $2.3 million during Q3 2025.
  • Moreover, its 3-year median value for Current Assets was $4.0 million (2024), whereas its average is $4.3 million.
  • Per our database at Business Quant, China Pharma Holdings' Current Assets surged by 70.87% in 2021 and then crashed by 45.47% in 2024.
  • Over the past 5 years, China Pharma Holdings' Current Assets (Quarterly) stood at $9.1 million in 2021, then slumped by 34.41% to $6.0 million in 2022, then climbed by 0.54% to $6.0 million in 2023, then plummeted by 45.47% to $3.3 million in 2024, then crashed by 37.70% to $2.3 million in 2025.
  • Its Current Assets stands at $2.3 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.9 million for Q1 2025.